Clinical Trial Update: Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL

View source ↗

Summary

This clinical trial update reports on hematological remission rates and survival among Chinese adults with B-precursor acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-precursor Acute Lymphoblastic Leukemia

Snippet

Sponsor: Harbin Hematology and Oncology Institute | Conditions: B-precursor Acute Lymphoblastic Leukemia | Status: COMPLETED